Cilates enzyme preparation - Cilian

Drug Profile

Cilates enzyme preparation - Cilian

Alternative Names: CEP - Cilian; Cilase

Latest Information Update: 12 Jul 2016

Price : $50

At a glance

  • Originator Cilian
  • Class Enzymes
  • Mechanism of Action Lipase replacements; Peptide hydrolase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Exocrine pancreatic insufficiency

Highest Development Phases

  • Preclinical Exocrine pancreatic insufficiency

Most Recent Events

  • 12 Jul 2016 Cilates enzyme preparation - Cilian is available for licensing as of 12 Jul 2016. http://www.cilian.com/
  • 12 Jul 2016 Preclinical trials in Exocrine pancreatic insufficiency in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top